Natural History of the Disease
Before embarking upon a discussion of the clinical vagaries of this neoplasm, it might be useful to review briefly some aspects of its development and behaviour. The old controversy as to whether the cellular progenitor of the tumour is renal or adrenal has been settled in recent years in favour of the former. However, the old term ' hypernephroma' is still in general use and will be used interchangeably with ' renal carcinoma'. Recent electron microscopic studies have illustrated certain close similarities between renal carcinoma cells and cells of normal convoluted tubules (Oberling, Riviere and Haguenau, I960 clear or granular cytoplasm. With certain exceptions which will be mentioned later, these variations do not seem to influence the behaviour of the tumour in any significant way. Early growth is clinically silent, and it is impossible to determine the duration of this phase. However, one may deduce from indirect evidence, such as the slow subsequent course which the tumour often runs and the long history of hlimaturia or other symptoms with which patients sometimes present, that this silent phase may conceivably extend over a period of years. Graham (1947) reported an average delay of one year and eight months from the time of the first symptom until investigation of the urinary tract was undertaken. When the tumour is small, metastases are uncommon. Bell (1938) found metastases in only one case out of 39 wherein the tumour did not exceed 3 cm. in diameter and in four of 22 cases with diameter between 3 and 5 cm. When the diameter was over 5 cm., metastases were found in 66 of 84 cases.
First symptoms occur with extension of the tumour toward the renal calyces and pelvis (haematuria), into the capsule and perinephric tissue (flank and abdominal pain) or renal venous network (symptomatic metastases). Hematuria, either gross or microscopic, is seen initially in roughly one-half the cases and develops later in others. However, failure to show positive urinary findings, even after other manifestations have been long present, is not uncommon and constitutes perhaps the most important diagnostic stumbling block. Melicow and Uson (I960) in a review of I83 cases which presented with ' non-urologic or atypical symptoms' (in a total group of 577 patients with renal cancer) found that 60% never had red blood cells in the urine. The kidney capsule usually remains intact until the tumour achieves a considerable size and becomes palpable in a variable proportion of cases (generally around one-third at initial presentation). Compression or infiltration of peri-renal structures may lead to dull flank, costovertebral or upper abdominal pain. Colicky pain is sometimes noted and is usually ascribed to passage of blood clots or bits of neoplastic tissue through the ureter. Local extension is not an important mode of spread in most cases. Occasionally atypical presenting symptoms are related to perinephric infiltration or hemorrhage. Bloom (I959) reported a case of chronic hiccoughs disappearing after removal of a renal carcinoma adherent to the diaphragm. A recent case (Case Records of the M.G.H., I962) presented with severe abdominal pain suggesting perforation of a viscus, later found to be due to perinephric himorrhage from a renal cancer. A case with intraperitoneal haemorrhage was reported by El-Toraei (1958) .
Lymphatic spread is not a common early occurrence, although at post-mortem examination regional peri-aortic nodes are involved in about one-quarter of the cases. In examining 509 kidneys with Heslin, Milner and Garlick, 1955) . Cystic lesions occur in association with renal carcinoma with a frequency which may be greater than would be expected by chance, although convincing statistical proof of this proposal has not been offered. Gibson (1954) , in discussing this subject, suggested that the mechanism for this might be combined tubular and vascular obstruction by the tumour resulting in impaired drainage of urine and devitalization of tissue in an area of kidney adjacent to the tumour. He cited animal experiments which support this conclusion and emphasized that a tubular or vascular lesion alone would be insufficient to produce a cystic area. In other cases the cyst seems to arise within the tumour probably as a result of necrosis and liquefaction, and in still others (Provet, Lisa and Trinidad, 1956 ) small tumours have been found in the walls of solitary cysts. The practical importance of this association lies in the realization that cysts are the most important renal lesions which enter into the differential diagnosis of renal carcinoma. The demonstration of a cyst by various diagnostic measures does not eliminatethe possibility of co-existing cancer. Cysts usually do not cause h2ematuria, pain, weight loss and other signs and symptoms commonly found with neoplasms, and if such are present exploration of the kidney is indicated.
Calcification within renal carcinomas has been reported in variable incidence, probably reflecting the authors' interest in the subject. Cahill and Melicow (I938) reported the highest incidence, 14 out of 82 tumours showing calcification by X-ray. Surprisingly, they found the prognosis to be much worse in these cases. In a recent review (Cannon, Evans, Halpern and Finby, I96I) in this differentiation, while Ney and Glanzman (1958) enjoyed similar success with presacral oxygen insufflation used in combination with pyelography. Abdominal venography has been used by Kaufman, Burke and Goodwin (I956) to define the extent of local spread and to investigate cases with possible recurrence after surgery. Cytologic studies of the urine have not proven to be as useful as in the diagnosis of lower genito-urinary tract malignancies. Evans, Halpern and Finby (I96I) report negative findings in all 55 cases tested. Others report false positives (Weyrauch and Presti, I9.56; Hazard, McCormack and Belovich, 1957) .
Anomalous Behaviour of Metastases
In all series of hypernephromas, a large proportion of patients are found to present with signs or symptoms produced by metastatic lesions. In this category one might also include those who seek medical attention because of weight loss, weakness or debility since most of these will be found to have metastatic disease (though not all since occasionally these constitutional symptoms disappear, never to recur, after nephrectomy).
About one-quarter to two-thirds of cases have evidence of metastatic disease when first admitted to the hospital, the wide range doubtlessly reflecting the thoroughness of investigation and duration of symptoms and signs before the initiation of diagnostic measures. The pattern of metastatic disease in renal carcinoma has peculiarities which distinguish it from other neoplasms and this subject will now be considered in some detail.
Solitary Metastases and Metastases to Unusual and Unexpected Sites
A voluminous literature attests to the fact that renal carcinoma may spread to extraordinary places and often may appear as a large, isolated metastatic lesion. This tendency may have some relationship to its early invasion of blood vessels and primary spread by the vascular route. Because of the distinctive histological picture of many renal cancers, biopsy of a metastasis often allows the pathologist to suggest the kidney as the site of origin. Pulmonary metastases are the most common. Large single lesions are easily confused with primary lung tumours. In several instances isolated involvement of the chest wall or mediastinal structures has been noted. A predilection for growth in the bronchial mucosa has provided several curious case reports. Creevy (1955) described a man with cough of three years duration who, on one occasion, coughed up a piece of tissue which, on histological examination, was diagnosed as carcinoma of undetermined origin. Chest X-ray showed an infiltration at the right hilus, suggesting bronchogenic carcinoma. The patient later had haematuria, and pyelography revealed a kidney tumour. Re-examination of the sections of the coughed-up specimen showed it to have an appearance consistent with that of hypernephroma.
A patient described by Caplan (Hyman, 1933) No experimental work directed at defining the responsible pyrogen has so far been reported.
Polycyth2mia
The occurrence of polycythemia with renal carcinoma was noted by Bliss in 1929 but was thought to be an incidental complication. A causal relationship was suggested later by Forssell (1946) . It would appear that renal carcinoma accounts for from I to 5% of cases of polycythoemia. The cause of the hypercalcaemia in these cases is not known. In those in whom the parathyroids were examined, either at operation or at autopsy, no abnormality was found, which makes it unlikely that the hypercalcoemic effect is mediated by the parathyroids. Note should be made, however, of the occurrence of renal cell carcinoma in a patient with primary hyperparathyroidism (Case Records of the M.G.H., 196Ic). Attempts to demonstrate a calcium-mobilizing factor in the tumours have been unsuccessful (Albright and Reifenstein, 1946; Plimpton and Gellhorn, 1956 ; Case Records of the M.G.H., I96Ib). It is likely, however, that these tumours are producing some substance (probably a polypeptide) that resembles the parathyroid hormone, since removal of the primary neoplasm has frequently resulted in return of the serum calcium and phosphorus to normal. From the available data, it is difficult to determine whether extensive tumour necrosis is necessary for the hypercalcoemic effect. The possibility that the hypercalcamia is due to abnormal binding of calcium in the serum has been discussed (Plimpton and Gellhorn, 1956; Huth, I96I) but is unlikely in view of the hypercalciuria sometimes observed, as well as the fact that symptoms referable to the hypercalcxemia per se have been described and have remitted after removal of the tumour. It is of interest that a transplantable papilloma in rabbits had produced hypercalcamia, hypophosphataemia and bone resorption unassociated with skeletal metastases (Wilson, Merric, and Woodward, i96I) . Similar findings in humans have also been observed with malignant tumours other than those from the kidney (Connor, Thomas and Howard, I956; Plimpton and Gellhorn, 1956; Huth, I96I) . Amyloidosis A small proportion of cases of secondary amyloidosis is related to malignant disease (Dixon, 1934) . If myeloma is excluded, renal carcinoma and Hodgkin's disease appear to be by far the most common malignancies associated with amyloidosis. Richmond, Sherman, Diamond and Craver (I962) found amyloid deposits in 3%0 of cases of Hodgkin's disease and none in other lymphomas. Over 30 cases have been reported with hypernephromas. Hyman and Leiter (I946) founid to be almost entirely replaced by a renal carcinoma. After nephrectomy the patient was able to conserve sodium normally. Apparently, for some obscure reason, the tumour resulted in a leakage of plasma-like fluid into the urine.
Arteriovenous Fistula. Hypernephromas tend to be rather vascular tumours. Mention has already been made of pulsating metastases. Some of these may result in shunting of blood sufficient to cause hiemodynamic changes (Caplan, Sparkes, Lemay and Mahoney, I96I) . Arteriovenous shunting may also be seen in the primary tumour. One patient (Bacon, 1958) The test may be of some diagnostic value if elevated, especially in distinguishing between renal carcinoma and cyst. Polycythemia with renal carcinoma may be associated with a higher sedimentation rate than polycythaemia vera. However, as is usually the case, the sedimentation rate gives nonspecific information which must be bolstered by more definitive data before one makes a decision for or against exploratory surgery.
Serum protein studies have been reported by Bottiger (ig6ob) who found a significant elevation of serum glycoproteins, alpha-2 globulins and haptoglobin. These changes returned toward normal with removal of the tumour. However, there is no definite evidence that these abnormalities differ basically from those which may be seen with many types of malignancy (Shetlar, I96I An interesting association between malignant tumours and Cushing's syndrome has been described. However, until I96I in none of the reported cases was renal carcinoma present. Riggs and Sprague (I96I) observed three patients with hypernephroma among 13 patients with malignant tumours and Cushing's syndrome. One of these patients was a 47-year-old female who had typical signs and laboratory findings of adrenocortical hyperfunction in addition to a small hypernephroma of the right kidney. Removal of the renal carcinoma and simultaneous subtotal resection of hyperplastic adrenals resulted in remission of the Cushing's disease. The possibility that the tumour was producing an ACTH-like substance was postulated but not proven in this case.
Concluding Remarks
In this review we have made no attempt to discuss treatment of renal carcinoma. However, it should be emphasized that in many cases the previously discussed systemic manifestations such asfever,polycythemia, hypercalczmia, myopathy, and perhaps amyloidosis may regress after removal of the tumour. Thus, these manifestations do not indicate inoperability in this disease where surgery is the treatment of choice.
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